By Emma Cueto ( April 19, 2018, 6:41 PM EDT) -- Bayer AG and Johnson & Johnson units have urged a Philadelphia judge to throw out an ongoing trial alleging the companies didn't provide an adequate warning for blood-thinner Xarelto, saying there was no evidence a stronger label would have prevented a patient who took the drug from nearly bleeding to death....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.